Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Clinical and Experimental Immunology
|
December 1, 1988
In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS)
J Troppmair, K Nachbaur, M Herold, et al.
Geburtshilfe Und Frauenheilkunde
|
November 1, 1989
[The intraperitoneal installation of gamma interferon for the treatment of refractory ovarian carcinoma]
C Marth, R Mull, G Gastl, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]
J Thaler, T Kühr, G Gastl, et al.
Seminars in Hematology
|
July 1, 1993
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group
J Thaler, G Gastl, T Fluckinger, et al.
British Journal of Cancer
|
July 1, 2004
Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)
M Fiegl, A Massoner, M Haun, et al.
Leukemia Research
|
January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin
J Thaler, H Denz, O Dietze, et al.
Journal of Interferon Research
|
October 1, 1988
Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha
W E Aulitzky, H Tilg, M Herold, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1986
Treatment of hairy-cell leukemia with recombinant alpha 2-interferon
Z N Berneman, G Gastl, D Gangji, et al.
Journal of Interferon Research
|
August 1, 1989
Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancer
W E Aulitzky, W Aulitzky, G Gastl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial
W E Aulitzky, H Tilg, G Gastl, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Clinical and Experimental Immunology
|
December 1, 1988
In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS)
J Troppmair, K Nachbaur, M Herold, et al.
Geburtshilfe Und Frauenheilkunde
|
November 1, 1989
[The intraperitoneal installation of gamma interferon for the treatment of refractory ovarian carcinoma]
C Marth, R Mull, G Gastl, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]
J Thaler, T Kühr, G Gastl, et al.
Seminars in Hematology
|
July 1, 1993
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group
J Thaler, G Gastl, T Fluckinger, et al.
British Journal of Cancer
|
July 1, 2004
Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)
M Fiegl, A Massoner, M Haun, et al.
Leukemia Research
|
January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin
J Thaler, H Denz, O Dietze, et al.
Journal of Interferon Research
|
October 1, 1988
Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha
W E Aulitzky, H Tilg, M Herold, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1986
Treatment of hairy-cell leukemia with recombinant alpha 2-interferon
Z N Berneman, G Gastl, D Gangji, et al.
Journal of Interferon Research
|
August 1, 1989
Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancer
W E Aulitzky, W Aulitzky, G Gastl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial
W E Aulitzky, H Tilg, G Gastl, et al.
Page
of 14